Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance.
Sign Up to like & getrecommendations! Published in 2020 at "Neurologia"
DOI: 10.1016/j.nrl.2020.11.006
Abstract: INTRODUCTION Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the incidence of new vascular events, although in a substantial… read more here.
Keywords: events patients; vascular events; prevention vascular; secondary prevention ... See more keywords
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance.
Sign Up to like & getrecommendations! Published in 2021 at "Neurologia"
DOI: 10.1016/j.nrleng.2020.11.014
Abstract: INTRODUCTION Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the incidence of new vascular events, although in a substantial… read more here.
Keywords: secondary prevention; prevention vascular; events patients; vascular events ... See more keywords
Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
Sign Up to like & getrecommendations! Published in 2019 at "Current vascular pharmacology"
DOI: 10.2174/1570161116666180206113755
Abstract: In Diabetes Mellitus (DM), hyperglycaemia and insulin resistance progressively lead to both microvascular and macrovascular complications. Whereas the incidence of microvascular complications is closely related to tight glycaemic control, this does not apply to macrovascular… read more here.
Keywords: arterial wall; macrovascular complications; prevention vascular; wall ... See more keywords